These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1051 related articles for article (PubMed ID: 17302588)
1. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588 [TBL] [Abstract][Full Text] [Related]
2. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea. Kim BW; Park YK; Kim YB; Wang HJ; Kim MW Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487 [TBL] [Abstract][Full Text] [Related]
3. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930 [TBL] [Abstract][Full Text] [Related]
4. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience. Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700 [TBL] [Abstract][Full Text] [Related]
5. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange. Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670 [TBL] [Abstract][Full Text] [Related]
6. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810 [TBL] [Abstract][Full Text] [Related]
7. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen. Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368 [TBL] [Abstract][Full Text] [Related]
12. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802 [TBL] [Abstract][Full Text] [Related]
13. A novel approach to successful ABO-incompatible high-titer renal transplantation. Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213 [TBL] [Abstract][Full Text] [Related]
14. Adult ABO-incompatible liver transplantation, using A and B donors. Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811 [TBL] [Abstract][Full Text] [Related]
15. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation. Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351 [TBL] [Abstract][Full Text] [Related]
16. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Tydén G; Kumlien G; Fehrman I Transplantation; 2003 Aug; 76(4):730-1. PubMed ID: 12973118 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
19. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980 [TBL] [Abstract][Full Text] [Related]
20. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports. Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]